Corrigendum
The authors wish to make the following corrections to their article: Mannaioni G, Lugoboni F. Precautions in the management of opioid agonist therapy: from target population characteristics to new formulations and post-marketing monitoring – a focus on the Italian system. Drugs Context. 2023;12:2023-2-6. https://doi.org/10.7573/dic.2023-2-6
Original Research
This study aims to evaluate the efficacy and safety of itopride in addressing upper gastrointestinal symptoms associated with gastroparesis specifically in patients with diabetes. By assessing the impact of itopride SR on symptom relief, this research intends to provide valuable insights into the potential benefits of itopride as a treatment option for gastroparesis.
Review
This review provides an update on the management of breakthrough cancer pain with fentanyl, with consideration of safety, as it remains an important tool in the treatment of cancer pain.
Case Report
In this article, the authors describe a case study of a 31-year-old woman known to have multiple sclerosis and concomitant severe central sleep apnoea (CSA). She received the medication dimethyl fumarate for the treatment of multiple sclerosis, and her CSA significantly improved to mild CSA after the treatment.
Review
The authors provide a comprehensive overview of clinicians’ adherence to heart failure guidelines in a specialized real-life setting, particularly regarding use and optimization of guideline-derived medical therapies, as well as the implementation of more recent agents. They seek potential explanations for suboptimal treatment and its impact on patient outcomes.
